Biotech: The Big Payoff
He believes Gilead and other biotechs are likely to seek M&A partners to fulfill public demand for new drugs. The beginning of the year brought a fraught narrative to the biotech space.
from Biotech News
He believes Gilead and other biotechs are likely to seek M&A partners to fulfill public demand for new drugs. The beginning of the year brought a fraught narrative to the biotech space.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments